Embecta Corp’s recently made public that its Director Melcher David F acquired Company’s shares for reported $32500.0 on Feb 12 ’24. In the deal valued at $16.25 per share,2,000 shares were bought. As a result of this transaction, Melcher David F now holds 45,080 shares worth roughly $0.48 million.
Then, Melcher David F bought 6,233 shares, generating $98,271 in total proceeds. Upon buying the shares at $15.77, the Director now owns 27,698 shares.
Before that, Kurdikar Devdatt bought 5,000 shares. Embecta Corp shares valued at $109,050 were divested by the President and CEO at a price of $21.81 per share. As a result of the transaction, Kurdikar Devdatt now holds 244,791 shares, worth roughly $2.58 million.
Wolfe Research initiated its Embecta Corp [EMBC] rating to a Peer perform in a research note published recently. A number of analysts have revised their coverage, including Morgan Stanley’s analysts, who decreased its forecast for the stock in early January from “an Equal-weight” to “an Underweight”. BTIG Research began covering EMBC with “Neutral” recommendation on September 08, 2022. Morgan Stanley started covering the stock on August 01, 2022. It rated EMBC as “an Equal-weight”.
Price Performance Review of EMBC
On Tuesday, Embecta Corp [NASDAQ:EMBC] saw its stock jump 1.54% to $10.55. Over the last five days, the stock has gained 4.15%. Embecta Corp shares have fallen nearly -44.27% since the year began. Nevertheless, the stocks have fallen -63.82% over the past one year. While a 52-week high of $32.00 was reached on 01/02/24, a 52-week low of $9.93 was recorded on 04/15/24. SMA at 50 days reached $12.15, while 200 days put it at $15.86. A total of 0.42 million shares were traded, compared to the trading of 0.45 million shares in the previous session.
Levels Of Support And Resistance For EMBC Stock
The 24-hour chart illustrates a support level at 10.41, which if violated will result in even more drops to 10.27. On the upside, there is a resistance level at 10.68. A further resistance level may holdings at 10.81. The Relative Strength Index (RSI) on the 14-day chart is 40.50, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at -0.08, which suggests price will go down in the next trading period. Percent R suggests that price movement has been low at 43.88%. Stochastics %K at 37.07% indicates the stock is a holding.
The most recent change occurred on June 21, 2022 when BofA Securities began covering the stock and recommended ‘”an Underperform”‘ rating along with a $25 price target.
